Thomas Hartung

Jonathan Blum, Markus Brüll, Jan G. Hengstler, et al. The long way from raw data to NAM-based information: Overview on data layers and processing steps. ALTEX - Alternatives to animal experimentation. 2025;42(1):167-180. doi:10.14573/altex.2412171

Eike Cöllen, Kristina Bartmann, Jonathan Blum, et al. Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testing. ALTEX - Alternatives to animal experimentation. 2025. doi:10.14573/altex.2501091

Yadvinder Bhuller, Marc Avey, Raywat Deonandan, et al. Ethical principles for regulatory risk decision-making. Regulatory Toxicology and Pharmacology. 2025:105813. doi:10.1016/j.yrtph.2025.105813

David Pamies, Jason Ekert, Marie-Gabrielle Zurich, et al. Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility. Stem Cell Reports. 2024;19(5):604-617. doi:10.1016/j.stemcr.2024.03.009

Michael Balls, Rolf Bass, Rodger Curren, et al. 60 Years of the 3Rs symposium: Lessons learned and the road ahead. Alternatives to Animal Experimentation. 2024;41(2):179-201. doi:10.14573/altex.2403061

Thomas Hartung. The (misleading) role of animal models in drug development. Frontiers in Drug Discovery. 2024;4. doi:10.3389/fddsv.2024.1355044

Lena Smirnova, Thomas Hartung. The Promise and Potential of Brain Organoids. Advanced Healthcare Materials. 2024:2302745. doi:10.1002/adhm.202302745

Lena Smirnova, Thomas Hartung. The Promise and Potential of Brain Organoids. Advanced Healthcare Materials. 2024;13(21):2302745. doi:10.1002/adhm.202302745

Thomas Hartung, Jeffrey John Bajramovic, Susan Gibbs, Emanuela Corsini. Editorial: New approach methods in immunology. Frontiers in Immunology. 2024;15. doi:10.3389/fimmu.2024.1488534

Nicole Kleinstreuer, Thomas Hartung. Artificial intelligence (AI)-it’s the end of the tox as we know it (and I feel fine). Archives of Toxicology. 2024. doi:10.1007/s00204-023-03666-2